Clinical Trial Update: Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update reports long-term efficacy and safety results for gabapentin enacarbil in Japanese patients with Restless Legs Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• gabapentin enacarbil (Horizant) (gabapentin enacarbil)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED